000 02386 a2200625 4500
005 20250517112515.0
264 0 _c20180213
008 201802s 0 0 eng d
022 _a1557-3265
024 7 _a10.1158/1078-0432.CCR-16-1274
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aPratz, Keith W
245 0 0 _aA Phase I Study of Topotecan, Carboplatin and the PARP Inhibitor Veliparib in Acute Leukemias, Aggressive Myeloproliferative Neoplasms, and Chronic Myelomonocytic Leukemia.
_h[electronic resource]
260 _bClinical cancer research : an official journal of the American Association for Cancer Research
_cFeb 2017
300 _a899-907 p.
_bdigital
500 _aPublication Type: Clinical Trial, Phase I; Journal Article
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aBenzimidazoles
_xadministration & dosage
650 0 4 _aCarboplatin
_xadministration & dosage
650 0 4 _aDisease-Free Survival
650 0 4 _aDose-Response Relationship, Drug
650 0 4 _aDrug-Related Side Effects and Adverse Reactions
_xpathology
650 0 4 _aFanconi Anemia Complementation Group D2 Protein
_xgenetics
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aLeukemia, Biphenotypic, Acute
_xdrug therapy
650 0 4 _aLeukemia, Myelomonocytic, Chronic
_xdrug therapy
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aMyeloproliferative Disorders
_xdrug therapy
650 0 4 _aPoly (ADP-Ribose) Polymerase-1
_xantagonists & inhibitors
650 0 4 _aTopotecan
_xadministration & dosage
700 1 _aRudek, Michelle A
700 1 _aGojo, Ivana
700 1 _aLitzow, Mark R
700 1 _aMcDevitt, Michael A
700 1 _aJi, Jiuping
700 1 _aKarnitz, Larry M
700 1 _aHerman, James G
700 1 _aKinders, Robert J
700 1 _aSmith, B Douglas
700 1 _aGore, Steven D
700 1 _aCarraway, Hetty E
700 1 _aShowel, Margaret M
700 1 _aGladstone, Douglas E
700 1 _aLevis, Mark J
700 1 _aTsai, Hua-Ling
700 1 _aRosner, Gary
700 1 _aChen, Alice
700 1 _aKaufmann, Scott H
700 1 _aKarp, Judith E
773 0 _tClinical cancer research : an official journal of the American Association for Cancer Research
_gvol. 23
_gno. 4
_gp. 899-907
856 4 0 _uhttps://doi.org/10.1158/1078-0432.CCR-16-1274
_zAvailable from publisher's website
999 _c26351254
_d26351254